KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $132.0 million.

  • Eli Lilly's Change in Acquisitions & Divestments rose 13571.43% to $132.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $964.0 million, marking a year-over-year increase of 15775.4%. This contributed to the annual value of $964.0 million for FY2025, which is 15775.4% up from last year.
  • Latest data reveals that Eli Lilly reported Change in Acquisitions & Divestments of $132.0 million as of Q4 2025, which was up 13571.43% from $556.1 million recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Change in Acquisitions & Divestments registered a high of $753.4 million during Q4 2021, and its lowest value of $4.0 million during Q1 2021.
  • In the last 5 years, Eli Lilly's Change in Acquisitions & Divestments had a median value of $85.1 million in 2022 and averaged $149.4 million.
  • In the last 5 years, Eli Lilly's Change in Acquisitions & Divestments plummeted by 8913.04% in 2021 and then surged by 193500.0% in 2022.
  • Over the past 5 years, Eli Lilly's Change in Acquisitions & Divestments (Quarter) stood at $753.4 million in 2021, then tumbled by 87.97% to $90.6 million in 2022, then plummeted by 64.9% to $31.8 million in 2023, then surged by 76.1% to $56.0 million in 2024, then soared by 135.71% to $132.0 million in 2025.
  • Its Change in Acquisitions & Divestments was $132.0 million in Q4 2025, compared to $556.1 million in Q3 2025 and $204.3 million in Q2 2025.